137 related articles for article (PubMed ID: 28414076)
1. Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity.
Bu L; Li W; Ming Z; Shi J; Fang P; Yang S
Life Sci; 2017 Jun; 178():35-41. PubMed ID: 28414076
[TBL] [Abstract][Full Text] [Related]
2. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
3. miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2.
Bu L; Tian Y; Wen H; Jia W; Yang S
Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):189-200. PubMed ID: 33332541
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
[TBL] [Abstract][Full Text] [Related]
5. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
[TBL] [Abstract][Full Text] [Related]
8. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
10. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Plasma Cellular Retinoic Acid-Binding Protein 2 and Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells.
Meng JF; Luo MJ; Li HB
Crit Rev Eukaryot Gene Expr; 2021; 31(3):81-89. PubMed ID: 34369716
[TBL] [Abstract][Full Text] [Related]
12. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D.
Zhang T; Hu Y; Ju J; Hou L; Li Z; Xiao D; Li Y; Yao J; Wang C; Zhang Y; Zhang L
Sci Rep; 2016 Jan; 6():19346. PubMed ID: 26783084
[TBL] [Abstract][Full Text] [Related]
14. Del-1 overexpression potentiates lung cancer cell proliferation and invasion.
Lee SH; Kim DY; Jing F; Kim H; Yun CO; Han DJ; Choi EY
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):92-8. PubMed ID: 26545781
[TBL] [Abstract][Full Text] [Related]
15. miR‑512‑5p suppresses proliferation, migration and invasion, and induces apoptosis in non‑small cell lung cancer cells by targeting ETS1.
Cao B; Tan S; Tang H; Chen Y; Shu P
Mol Med Rep; 2019 May; 19(5):3604-3614. PubMed ID: 30896817
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
17. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
20. High level of BRD4 promotes non-small cell lung cancer progression.
Liao YF; Wu YB; Long X; Zhu SQ; Jin C; Xu JJ; Ding JY
Oncotarget; 2016 Feb; 7(8):9491-500. PubMed ID: 26840017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]